In radical prostatectomy, 'the future is robotic'

Las Vegas--The development of a robot-assisted method for laparoscopic radical prostatectomy could lessen morbidity, cut recovery times, and shorten the learning curve for urologists who have not been trained in the procedure.

Related Videos

Related Content

Advertisement

April 27th 2025

UGN-102 positions itself as an alternative to TURBT for low-grade NMIBC

Benjamin P. Saylor

"I would argue that UGN-102 may very well represent a well-tolerated alternative to TURBT as primary treatment for patients with low-grade disease,” says Sandip M. Prasad, MD, MPhil.

April 27th 2025

Pearls & Perspectives: Updates in Testosterone Therapy, with Andrew Sun, MD at AUA 2025

Amy M. Pearlman, MD Andrew Y. Sun, MD

Andrew Sun, MD, joins Pearls & Perspectives to discuss innovative approaches to testosterone therapy for enhanced health outcomes.

April 27th 2025

Estimated DOR of 2 years is seen with UGN-102 in LG-IR-NMIBC

Benjamin P. Saylor

The investigators reported that the median Kaplan-Meier estimate of DOR was 24.2 months.

April 27th 2025

Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025

Amy M. Pearlman, MD Helen L. Bernie, DO, MPH

Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.

April 26th 2025

Drinking water contaminants could increase risk of kidney stones, study finds

Patrick Campbell

New research links higher drinking water contaminants to increased kidney stone risk.

April 26th 2025

CREST: Significant EFS boost seen with sasanlimab plus BCG in NMIBC

Benjamin P. Saylor

“In the patients with CIS, the probability of a continued complete response at 36 months was 92% vs 67.7%," said Neal D. Shore, MD, FACS.

Related Content

Advertisement

April 27th 2025

UGN-102 positions itself as an alternative to TURBT for low-grade NMIBC

Benjamin P. Saylor

"I would argue that UGN-102 may very well represent a well-tolerated alternative to TURBT as primary treatment for patients with low-grade disease,” says Sandip M. Prasad, MD, MPhil.

April 27th 2025

Pearls & Perspectives: Updates in Testosterone Therapy, with Andrew Sun, MD at AUA 2025

Amy M. Pearlman, MD Andrew Y. Sun, MD

Andrew Sun, MD, joins Pearls & Perspectives to discuss innovative approaches to testosterone therapy for enhanced health outcomes.

April 27th 2025

Estimated DOR of 2 years is seen with UGN-102 in LG-IR-NMIBC

Benjamin P. Saylor

The investigators reported that the median Kaplan-Meier estimate of DOR was 24.2 months.

April 27th 2025

Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025

Amy M. Pearlman, MD Helen L. Bernie, DO, MPH

Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.

April 26th 2025

Drinking water contaminants could increase risk of kidney stones, study finds

Patrick Campbell

New research links higher drinking water contaminants to increased kidney stone risk.

April 26th 2025

CREST: Significant EFS boost seen with sasanlimab plus BCG in NMIBC

Benjamin P. Saylor

“In the patients with CIS, the probability of a continued complete response at 36 months was 92% vs 67.7%," said Neal D. Shore, MD, FACS.